Therefore, the elaboration of novel clinical practice guidelines have established a non-invasive diagnostic strategy for patients with cardiac amyloidosis based on the Perugini score, stating that a score of 2 or 3 and the absence of blood dyscrasia, represent enough evidence for TTR cardiac amyloidosis diagnosis [14]. The gene discussed is TTR; the disease is cardiac amyloidosis.